GAMCO Investors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-14,445
Closed -$141K – 890
2024
Q2
$141K Sell
14,445
-11,500
-44% -$140K ﹤0.01% 845
2024
Q1
$392K Sell
25,945
-1,350
-5% -$24.5K ﹤0.01% 723
2023
Q4
$588K Sell
27,295
-35,700
-57% -$659K 0.01% 675
2023
Q3
$1.17M Sell
62,995
-23,758
-27% -$555K 0.01% 556
2023
Q2
$2.2M Sell
86,753
-7,245
-8% -$182K 0.02% 464
2023
Q1
$2.43M Sell
93,998
-201
-0.2% -$5.38K 0.03% 444
2022
Q4
$2.23M Sell
94,199
-34,237
-27% -$923K 0.02% 455
2022
Q3
$3.26M Sell
128,436
-15,225
-11% -$534K 0.04% 385
2022
Q2
$4.77M Buy
143,661
+4,550
+3% +$193K 0.05% 319
2022
Q1
$10M Buy
139,111
+4,850
+4% +$349K 0.09% 241
2021
Q4
$12.3M Sell
134,261
-12,577
-9% -$1.5M 0.11% 221
2021
Q3
$18.6M Sell
146,838
-15,562
-10% -$2.27M 0.16% 168
2021
Q2
$27M Sell
162,400
-12,457
-7% -$2.02M 0.23% 125
2021
Q1
$31.8M Sell
174,857
-2,368
-1% -$549K 0.28% 108
2020
Q4
$35.4M Buy
177,225
+1,075
+0.6% +$219K 0.33% 86
2020
Q3
$38.6M Sell
176,150
-19,750
-10% -$4.18M 0.43% 64
2020
Q2
$37.4M Sell
195,900
-28,750
-13% -$5.04M 0.43% 65
2020
Q1
$34.8M Buy
224,650
+4,050
+2% +$471K 0.41% 67
2019
Q4
$18.5M Buy
220,600
+49,250
+29% +$3.75M 0.15% 177
2019
Q3
$11.6M Sell
171,350
-10,500
-6% -$691K 0.1% 227
2019
Q2
$12.1M Buy
181,850
+11,900
+7% +$694K 0.09% 236
2019
Q1
$9.45M Buy
169,950
+19,550
+13% +$1.19M 0.07% 261
2018
Q4
$7.46M Buy
150,400
+47,804
+47% +$2.93M 0.06% 285
2018
Q3
$8.86M Buy
102,596
+48,696
+90% +$3.47M 0.06% 284
2018
Q2
$3.13M Buy
53,900
+28,900
+116% +$1.41M 0.02% 425
2018
Q1
$1.01M Sell
25,000
-2,000
-7% -$75.5K 0.01% 558
2017
Q4
$941K Buy
+27,000
New +$897K 0.01% 581

Other funds holding TDOC

GAMCO Investors's TDOC Position: Q3 2024 in Review

GAMCO Investors sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 14,445 shares — an estimated $141K sold.

GAMCO Investors first reported a position in TDOC in Q4 2017 and held it in 27 quarters. The position peaked at $38.6M in Q3 2020. 366 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • GAMCO Investors reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
  • GAMCO Investors sold 14,445 Teladoc Health shares in Q3 2024, an estimated $141K.
  • GAMCO Investors first reported a position in Teladoc Health in Q4 2017 and held it in 27 quarters.
  • GAMCO Investors's Teladoc Health position peaked at $38.6M in Q3 2020.
  • 366 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on GAMCO Investors's 13F filing for Q3 2024, filed 14 Nov 2024.